Particulars |
Company Name |
Bliss GVS Pharma Ltd |
Year End |
2024/03 |
Full Year |
Equity (Rs Cr.) |
10.47 |
B.V (Rs) |
94.40 |
Sales (Rs Cr.) |
605.46 |
NP. (Rs Cr.) |
75.85 |
NP Var% |
-11.00 |
Div% |
50.00 |
CPS (Rs) |
9.50 |
EPS (Rs) |
7.20 |
Traded Value (Rs Lakhs) |
14.05 |
52 Week High |
149.00 |
52 Week Low |
71.00 |
Price BSE |
110.00 |
Price NSE |
110.00 |
Market Capital (Rs Cr.) |
1,155.79 |
P/C Ratio |
11.60 |
P/E Ratio |
15.20 |
Price Vs.BV |
1.17 |
|
Latest Quarter |
Year End |
202403 |
Sales (Rs Cr.) |
163.82 |
NP (Rs Cr.) |
23.64 |
NP Var % |
287.00 |
Trailing Twelve Months |
Year End |
202403 |
Sales |
615.03 |
OPM |
22.34 |
NP |
94.38 |
NP Var% |
-11.00 |
EPS |
7.24 |
PE |
15.25 |
|
|